Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04259229 · ClinicalTrials.gov registry record · NA
Mediterranean Diet and Mushrooms
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT04259229: Completed NA study, sponsored by Purdue University.
NCT04259229 is a NA study that has completed, run by Purdue University. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04259229, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The investigators propose to assess the effects of including mushrooms as part of a healthy eating pattern on indices of perceived mental health/anxiety/depression, along with risk factors for cardiovascular disease and type 2 diabetes.
Primary Outcome
Beck's Depression Inventory questionnaire
Interventions
- OTHER Mediterranean Diet -- Mushrooms
- OTHER Mediterranean Diet -- Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
What the finished NCT04259229 record still lists
NCT04259229 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Mediterranean Diet -- Mushrooms is the first listed.
NCT04259229 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04259229 about?
NCT04259229 is a clinical study titled "Mediterranean Diet and Mushrooms". The investigators propose to assess the effects of including mushrooms as part of a healthy eating pattern on indices of perceived mental health/anxiety/depression, along with risk factors for cardiovascular disease and type 2 diabetes.
What is the current status of trial NCT04259229?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2021-01-01. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04259229?
The interventions under investigation include: Mediterranean Diet -- Mushrooms (OTHER), Mediterranean Diet -- Control (OTHER).
Who is sponsoring clinical trial NCT04259229?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04259229's enrollment target sits among peer trials
53 1271st of 2000 higher than 729 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI